Table 1.
Patient, tumour characteristics and disease stages for 53 breast cancers on 50 patients
|
Age [years] |
Median |
68 |
|---|---|---|
| Range | 36-88 | |
| T |
pT1mi |
1 (2%) |
| |
pT1a |
6 (11%) |
| |
pT1b |
11 (21%) |
| |
pT1c |
20 (38%) |
| |
pT2 |
15 (28%) |
| N |
pN0 |
49 (92%) |
| |
pN1 |
4 (8%) |
| Histology |
IDC |
41 (77%) |
| |
ILC |
10 (19%) |
| |
Other Invasive |
2 (4%) |
| |
DCIS |
0 (0%) |
| Grading |
I |
10 (19%) |
| |
II |
38 (72%) |
| |
III |
5 (9%) |
| Estrogen Receptors |
Positive |
49 (92%) |
| |
Negative |
4 (8%) |
| Progesterone Receptors |
Positive |
46 (87%) |
| |
Negative |
7 (13%) |
| Her-2/neu |
Overexpressed |
1 (2%) |
| |
Not overexp. |
52 (98%) |
| Ki-67 |
≥20 |
3 (6%) |
| |
<20 |
50 (94%) |
| Disease Stage |
0 |
0 (0%) |
| |
I |
43 (81%) |
| II | 10 (19%) |
IDC: invasive ductal carcinoma; ILC: invasive lobular carcinoma; DCIS: ductal carcinoma in situ.